Home Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
Article Open Access

Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression

  • Wei Duan and Mengyu Cheng EMAIL logo
Published/Copyright: August 29, 2023

Abstract

We aimed to investigate the potential diagnostic value of five serum neuroactive substances in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated with depression. A total of 103 patients with AECOPD were enrolled between August 2020 and August 2021. All patients were assessed using a self-rating depression scale and divided into AECOPD with or without depression groups. Baseline data and serum neuroactive substance levels were compared between the two groups. Logistic regression was used to identify the risk factors. The diagnostic performance of neuroactive substances was evaluated using receiver operating characteristic (ROC) curves. Patients with AECOPD complicated with depression exhibited higher partial pressure of CO2 values and higher chronic obstructive pulmonary disease assessment test (CAT) scores. An elevated proportion of patients with more than two acute exacerbations (AEs) in the previous year was observed in this patient group (all P < 0.001). The CAT score and number of AEs during the previous year were identified as independent risk factors for AECOPD complicated with depression. No significant differences were observed in the levels of aspartic acid and glutamate between the two groups (P > 0.05). Serum γ-aminobutyric acid (GABA) and glycine (Gly) levels were decreased. In contrast, serum nitric oxide (NO) levels were increased in the AECOPD complicated with the depression group (P < 0.05). Serum GABA and Gly levels exhibited a negative correlation, and NO levels positively correlated with the number of AEs in the previous year and the CAT score. The area under the ROC curve values for GABA, Gly, and NO were 0.755, 0.695, and 0.724, respectively. Serum GABA exhibited a sensitivity of 85.1% and a specificity of 58.9%, below the cut-off value of 4855.98 nmol/L. Serum GABA, Gly, and NO may represent potential biomarkers for AECOPD complicated with depression.

Graphical abstract

1 Introduction

Chronic obstructive pulmonary disease (COPD), caused by exposure to inhaled noxious particles, mainly those present in tobacco smoke and gaseous pollutants, is the most common chronic respiratory disease and is considered a major cause of increased morbidity, mortality, and healthcare burden throughout the world [1]). A recent systematic review and modeling study revealed that when using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) definition, the incidence of COPD worldwide was 10.3% among individuals aged 30–79 in 2019 and accounted for approximately 391.9 million cases that occurred predominantly in low- and middle-income countries [2]. COPD is associated with multiple comorbidities such as osteoporosis, cardiovascular disease, and depression [3,4], which can negatively affect disease prognosis.

Depression is one of the most common comorbidities of COPD. The prevalence of depression has been reported at 7–80% in outpatients with COPD and 10–42% in the stable stage of COPD [5]. For example, in a cross-sectional observational study of 530 stable patients with COPD, 21.5% of patients suffered depression [6]. Depression is associated with decreased treatment compliance, a poor prognosis, high mortality, frequent hospitalizations, and poor quality of life [7]. Current evidence suggests a bidirectional association between COPD and clinical depression [8]. COPD increases the risk of developing depression. A large UK population-based cohort study indicated a depression incidence rate of 11.4 per 1,000 person-years in patients with COPD and 5.7 per 1,000 person-years in COPD-free populations. The patients with COPD exhibited a 41% higher risk of depression than those without COPD after adjustment [9]. In contrast, comorbid depression consistently increases the risk of exacerbation and mortality [8].

Nevertheless, the diagnosis of comorbid depression by respiratory clinicians is challenging and inadequate due to its overlapping symptoms with COPD. Less than one-third of the patients receive timely diagnosis and effective treatment [10]. Evidence indicates that gaseous neurotransmitters such as nitric oxide (NO) and amino acid neurotransmitters such as glutamate (Glu), γ-aminobutyric acid (GABA), aspartic acid (Asp), and glycine (Gly) play important roles in the pathogenesis of depression [11,12]. Changes in neurotransmitter levels have been reported in the cerebrospinal fluid, different brain regions, urine, and blood of patients with depressive disorder. Thus, they can be used as biomarkers for evaluating nervous system activities [13,14]. Additionally, these neurotransmitters are involved in COPD. For example, NO was determined to be a crucial effector in airflow obstruction and the development of COPD [15]. Multiple neurotransmitters and receptors, including GABA, Glu, and Gly, have been reported to be expressed in bronchial epithelial cells and interact with each other in a manner similar to that of neuron-like interactions to regulate physiological functions [16]. For example, GABA secreted by lung neuroendocrine and airway epithelial cells plays significant roles in regulating airway mucus secretion and the development of pulmonary hypertension [16,17]. However, only a few studies have investigated the associations of these neuroactive substances with COPD and depression.

Acute exacerbation of COPD (AECOPD) is characterized by the acute worsening of respiratory symptoms [18]. AECOPD and depression frequently co-occur. In a prospective observational study based on 288 patients with AECOPD, depression was confirmed in 41.7% of patients, and probable depression was diagnosed in 67.7% [19]. Therefore, depression should be systematically screened in patients with AECOPD, and timely and personalized therapeutic interventions should be provided. In this study, we aimed to investigate the potential value of neuroactive substances as biomarkers for screening patients with AECOPD complicated with depression. Our findings can aid in screening, diagnosing, and treating AECOPD complicated with depression.

2 Methods

2.1 Study design

Patients diagnosed with AECOPD (n = 103) in the Department of Respiratory and Critical Care Medicine at the Third Hospital of Shanxi Medical University from August 2020 to August 2021 were recruited for this study. Depression was assessed in all patients, and they were assigned to the AECOPD without depression and AECOPD with depression groups. All enrolled patients signed informed consent forms before they participated in this study. This study was approved by the Ethics Committee of the Third Hospital of Shanxi Medical University (Approval No. YXLL-2019-073) and complied with the Declaration of Helsinki.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by Ethics Committee of the Third Hospital of Shanxi Medical University (Approval No. YXLL-2019-073).

2.2 Inclusion and exclusion criteria

Inclusion criteria were as follows: (1) COPD was diagnosed based on the 2020 GOLD diagnostic criteria for COPD [20]; (2) AECOPD was determined according to the definition of an acute worsening of respiratory symptoms (including an increased degree of dyspnea and cough, purulent sputum, or increases in sputum) that resulted in the need for additional treatment; (3) patients greater than 40 years of age who possessed normal cognitive and language skills and were capable of barrier-free communications; and (4) patients with reimbursable medical expenses and fixed reimbursement rates for medical expenses according to the payment methods. Exclusion criteria were as follows: (1) patients with chronic respiratory diseases requiring treatment and intervention such as active pulmonary tuberculosis, pulmonary thromboembolism, interstitial pulmonary disease, chronic thromboembolic pulmonary hypertension, and others; (2) patients with extensive pleural effusion and pneumothorax and patients who cannot tolerate a 6-min walk; (3) patients who were diagnosed with mental illnesses such as anxiety, depression, and bipolar disorder prior to COPD diagnosis; (4) patients with severe cardiovascular disease and severe hepatic and renal insufficiency; (5) patients who had sequelae of cerebral infarction or cerebral hemorrhage and patients who had neuromuscular diseases; and (6) patients with solid tumors or hematological malignancy.

2.3 Data collection

Demographic and clinical pathological data, including age, sex, body mass index (BMI), number of pack-years of cigarette smoking, partial pressure of oxygen (PaO2), carbon dioxide (PaCO2), COPD assessment test (CAT) scores, pulmonary function, GOLD stages, number of acute exacerbations (AEs) in the previous year, and laboratory results within 24 h after hospitalization, were collected. The number of pack-years of cigarette smoking was defined as the number of packs (20 cigarettes) smoked per day multiplied by the total number of years of smoking [21]. Disease severity was categorized according to the GOLD staging criteria (GOLD stage I, II, III, or IV) that were determined depending on the post-bronchodilator forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) [22]. The CAT score is a simple and reliable measure developed to evaluate the symptoms and impact of COPD on health status, and it involves eight items with a total score ranging from 0 to 40 [23,24].

2.4 Arterial blood gas and pulmonary function tests

Arterial blood (2 mL) was collected within half an hour after admission for use in arterial blood gas analysis on an automated blood gas analyzer (GEM-3500; USA), and PaO2, PaCO2, and oxygen absorption concentrations were recorded. The forced expiratory volume in 1 s as a percentage of predicted value (FEV1%pred) and FEV1/FVC were measured using the master-Screen pulmonary function test system (Jaeger Co., Germany).

2.5 Laboratory tests

Venous blood (5 mL) was collected on an empty stomach within 24 h after hospitalization, and supernatants were collected after centrifuging at 3,000 rpm for 20 min and subsequently utilized for determining the levels of NO, Glu, Asp, Gly, and GABA. Briefly, NO levels were determined using biochemical methods, and the levels of Glu, Asp, Gly, and GABA were determined using corresponding enzyme-linked immunosorbent assay kits (Shanxi Boao Xinyuan Biotechnology Co., LTD) according to the manufacturer’s protocol.

2.6 Self-rating depression scale (SDS)

The SDS is a widely used self-reporting measure designed based on the diagnostic criteria for depression that includes 20 items involving psychological and physiological symptoms, where 10 items express negative experiences and 10 items express positive experiences. Depression in all patients was assessed by rating each item according to how they felt within the past week using a 4-point scale. The score for each of the 20 items was added to obtain a raw score multiplied by 1.25 to generate a standard score. A standard score of 53 indicates clinically significant depression symptoms and includes three levels of severity: mild (standard score ranging from 53 to 62), moderate (standard score ranging from 63 to 72), and severe (standard score more than 72).

2.7 Statistical analysis

All statistical analyses were conducted using SPSS 25.0 (IBM, Armonk, New York). Measurement data subjected to normal distribution are represented as the mean ± standard deviation and were compared using independent sample t-tests. Measurement data that did not conform to the normal distribution are represented as the median (interquartile spacing) and were compared using the Wilcoxon rank-sum test. Counting data are provided as frequency counts and composition ratios and were compared using Chi-square tests. Spearman’s or Pearson’s correlation was used to explore the correlations between neuroactive substances and pathological characteristics. Logistic regression was used to identify the risk factors for patients with AECOPD. The diagnostic performance of neuroactive substances was evaluated using receiver operating characteristic (ROC) curves. Statistical significance was set at P < 0.05.

3 Results

3.1 Clinical baseline characteristics of patients

A total of 103 patients with AECOPD were enrolled, and they were assigned into AECOPD without depression (n = 56) and AECOPD with depression (n = 47) groups after the depression assessment, according to SDS. Table 1 lists the baseline demographic and clinicopathological data for all patients. Sex (male proportion: 85.1 vs 87.5%, P = 0.724) and mean age (68.9 ± 9.5 vs 66.6 ± 9.2, P = 0.226) were not significantly different between the AECOPD with or without depression groups. Additionally, BMI (21.9 ± 3.8 vs 22.9 ± 3.3, P = 0.142) and the number of pack-years of cigarette smoking (38 [30–50] vs 35 [23.5–49.5], P = 0.396), two factors that were considered confounding factors, were not significantly different between the AECOPD with or without depression groups. These results indicated high comparability between the two groups.

Table 1

Comparison of demographics and clinical pathological data between the AECOPD group and the AECOPD with depression group

AECOPD with depression (n = 47) AECOPD without depression (n = 56) χ 2/t/Z P value
Sex 0.125 0.724
 Males 40 (85.1%) 49 (87.5%)
 Females 7 (14.9%) 7 (12.5%)
Age (years) 68.9 ± 9.5 66.6 ± 9.2 −1.218 0.226
BMI (kg/m2) 21.9 ± 3.8 22.9 ± 3.3 1.482 0.142
Numbers of pack-years of cigarette smoking 38 (30–50) 35 (23.5–49.5) −0.849 0.396
PaO2 (mmHg) 70.42 ± 10.81 70.75 ± 7.97 0.173 0.863
PaCO2 (mmHg) 43.66 ± 6.56 40.32 ± 5.53 −2.809 0.006
FEV1%pred 57.46 ± 16.22 59.46 ± 16.96 0.607 0.545
CAT score 26.34 ± 5.34 16.98 ± 5.46 −8.754 0.000
GOLD stages −0.449 0.654
 Stage I 5 (10.60%) 7 (12.5%)
 Stage II 25 (53.2%) 30 (53.6%)
 Stage III 12 (25.5%) 14 (25.0%)
 Stage IV 5 (10.6%) 5 (8.9%)
Numbers of AEs in the previous year −6.843 <0.001
 0–1 5 (10.6%) 44 (78.6%)
 ≥2 42 (89.4%) 12 (21.4%)

AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BMI, body mass index; PaO2, partial pressure of oxygen; PaCO2, partial pressure of carbon dioxide. FEV1%pred, forced expiratory volume in 1 s as percentage of predicted value; CAT, the COPD assessment test; GOLD, Global initiative for chronic obstructive lung disease.

Regarding clinical pathological characteristics, PaO2 (70.42 ± 10.81 vs 70.75 ± 7.97, P = 0.863), FEV1%pred (57.46 ± 16.22 vs 59.46 ± 16.96, P = 0.545), and GOLD stages (P = 0.654) did not exhibit statistically significant differences between the two groups. Patients in the AECOPD with depression group possessed higher PaCO2 than did those in the AECOPD without depression group (43.66 ± 6.56 vs 40.32 ± 5.53, P = 0.006). Elevated CAT scores (26.34 ± 5.34 vs 16.98 ± 5.46, P < 0.001) and proportion of patients with AEs in the previous year (>2 times, 42 [89.4%] vs 12 [21.4%], P < 0.001] in the AECOPD with depression group compared to these values in the AECOPD without depression group (Table 1) were observed.

3.2 Risk factors associated with AECOPD complicated with depression

Considering that patients in the AECOPD with depression group exhibited significantly increased PaCO2, CAT scores, and proportions of more than two AEs compared to those in the AECOPD without depression group, we further conducted logistic regression on these factors to identify the potential risk factors associated with AECOPD complicated with depression. As discussed in Table 2, the CAT score (1.271, 95% CI: 1.118–1.445, P < 0.001) and number of AEs in the previous year (12.069, 95% CI: 3.436–42.386, P < 0.001) were independent risk factors for AECOPD complicated with depression.

Table 2

Independent risk factors in logistic regression model

Variables Coefficient Standard error E P 95% CI
CAT score 0.24 0.065 1.271 0.000 1.118–1.445
Number of AEs in the previous year 2.491 0.641 12.069 0.000 3.436–42.386

CAT, the COPD assessment test. Logistic regression identified CAT score and number of AEs in the previous year as independent risk factors of AECOPD combined with depression.

3.3 Association of serum neuroactive substances with AECOPD complicated with depression

In addition to Glu and Asp, the other neuroactive substances exhibited statistically significant differences between the two groups (Table 3). Patients in the AECOPD with depression group possessed markedly decreased levels of serum GABA (4785.31 ± 73.35 vs 4860.62 ± 69.90, P < 0.001) and Gly (175.94 ± 7.22 vs 181.78 ± 9.48, P = 0.001) and markedly increased levels of serum NO (201.85 ± 9.48 vs 194.62 ± 6.71, P < 0.001) compared to levels in the patients in the AECOPD without depression group. Serum levels of GABA, Gly, and NO exhibited significant correlations with the two identified independent risk factors for AECOPD complicated with depression (Table 4). Serum levels of GABA and Gly were negatively correlated with both the CAT score (GABA, r = −0.347, P < 0.01; Gly, r = −0.264, P < 0.01) and the number of AEs in the previous year (GABA, r = −0.215, P < 0.05; Gly, r = −0.361, P < 0.01). The serum level of NO was positively correlated with the CAT score (r = 0.244, P < 0.05) and the number of AEs in the previous year (r = 0.238, P < 0.05). These findings suggest a close association of serum neuroactive substances (GABA, Gly, and NO) with AECOPD complicated with depression.

Table 3

Comparison of serum neuroactive substances between the AECOPD group and the AECOPD with depression group

AECOPD with depression (n = 47) AECOPD without depression (n = 56) t P
GABA (nmol/L) 4785.31 ± 73.35 4860.62 ± 69.90 5.325 0.000
Glu (μmol/L) 24.54 ± 1.62 24.27 ± 1.60 −0.865 0.389
Asp (μmol/L) 27.06 ± 1.78 27.69 ± 2.01 1.673 0.098
Gly (μmol/L) 175.94 ± 7.22 181.78 ± 9.48 3.46 0.001
NO (μmol/L) 201.85 ± 9.48 194.62 ± 6.71 −4.386 0.000

AECOPD, acute exacerbation of chronic obstructive pulmonary disease; GABA, gammaaminobutyric acid; Glu, glutamic acid; Asp, aspartic acid; Gly, glycine; NO, nitric oxide. Five serum neuroactive substances were compared between AECOPD petientis with or without depression, and three among which were significantly changed between groups in addition to aspartic acid (Asp) and glutamic acid (Glu).

Table 4

Correlations of serum neuroactive substances with independent risk factors

Variables GABA Gly NO Glu Asp
CAT score −0.347** −0.264** 0.244* −0.034 −0.052
Number of AEs in the previous year −0.215* −0.361** 0.238* 0.082 −0.187

CAT, the COPD assessment test; GABA, gammaaminobutyric acid; Glu, glutamic acid; Asp, aspartic acid; Gly, glycine; NO, nitric oxide. *P < 0.05; **P < 0.01. Correlations between levels of five serum neuroactive substances and two identified independent risk factors of AECOPD combined with depression were investigated, and significant correlations were found for three serum neuroactive substances in addition to aspartic acid (Asp) and glutamic acid (Glu).

3.4 Diagnostic value of serum neuroactive substances

Serum levels of GABA, Gly, and NO differed significantly between the two AECOPD groups. They were significantly correlated with the two independent risk factors. Based on this, their diagnostic value in AECOPD complicated with depression was further investigated (Figure 1; Table 5). The area under the ROC curve (AUC) of serum GABA for the diagnosis of AECOPD complicated with depression was 0.755 with a specificity of 58.9% and a sensitivity of 85.1% when serum GABA was <4,855.98 nmol/L. The AUC of serum Gly for the diagnosis of AECOPD complicated with depression was 0.695, with a specificity of 53.6% and a sensitivity of 83.0% when serum Gly was <180.01 μmol/L. The AUC of serum NO for the diagnosis of AECOPD complicated with depression was 0.724 with a specificity of 82.1% and a sensitivity of 61.7% when serum NO was >199.91 μmol/L. These results indicate that serum GABA possesses an optimal diagnostic value (largest AUC value and diagnostic sensitivity) compared to that of the other two neuroactive substances. However, the diagnostic specificity of serum GABA remains unsatisfactory.

Figure 1 
                  Diagnostic performance of γ-aminobutyric acid (GABA), Gly, and NO as evaluated using receiver operator characteristic curves.
Figure 1

Diagnostic performance of γ-aminobutyric acid (GABA), Gly, and NO as evaluated using receiver operator characteristic curves.

Table 5

Diagnostic performance of GABA, Gly, and NO for AECOPD with depression

AUC Sensitivity (%) Specificity (%) 95% CI Cut-off value P
GABA (nmol/L) 0.755 85.10 58.90 0.663–0.847 4855.98 <0.001
Gly (μmol/L) 0.695 83.00 53.60 0.593–0.797 180.01 0.001
NO (μmol/L) 0.724 61.70 82.10 0.622–0.826 199.91 <0.001

AUC, area under curves; GABA, gammaaminobutyric acid; Gly, glycine; NO, nitric oxide. Among five serum neuroactive substances, levels of only GABA, Gly, and NO were changed in AECOPD and significantly correlated with the independent risk factors of AECOPD combined with depression. Thus, the performance of serum GABA, Gly, and NO levels in diagnostic AECOPD was evaluated using receiver operator characteristic (ROC) curves. The area under ROC curves (AUC) was close to or greater than 0.7, indicating a good predictive performance.

4 Discussion

In this study, compared to those in patients with AECOPD without depression, we observed that serum levels of the neuroactive substances GABA and Gly were significantly decreased. The serum levels of NO were significantly increased in patients with AECOPD with depression symptoms. In addition, serum levels of GABA, Gly, and NO were closely correlated with the two independent risk factors (CAT score and number of AEs in the previous year) that were associated with AECOPD complicated with depression. Furthermore, ROC curves demonstrated the diagnostic value of GABA (AUC = 0.755), Gly (AUC = 0.695), and NO (AUC = 0.724) in the context of AECOPD complicated with depression. These findings indicated that serum GABA, Gly, and NO may be biomarkers to screen patients with AECOPD with depression.

Compared to the AECOPD without depression group, the AECOPD with depression group exhibited a high CAT score and a high proportion of more than two AEs in the previous year. This result was consistent with the results reported in a previous study [25]. In addition, these two factors were identified as independent risk factors. A previous study identified the CAT score as an independent risk factor for AECOPD with depression, and positive correlations between the CAT score and Hamilton Depression Rating Scale score (r 2 = 0.587) were observed [26]. Regarding AE numbers, it was observed that depression was related to an increased risk for exacerbations in COPD [27]. In a nationwide multicenter patient registry study, canonical correlation analysis revealed that 11% of the variance was shared between psychological symptoms (anxiety and depression) and four COPD outcome variables, including CAT, number of AEs, predicted FEV1%, and the modified medical research council dyspnea scale [28]. Further analysis revealed a positive correlation between depression and COPD outcomes, thus indicating that greater depression was associated with poorer CAT and more AEs [28]. This was consistent with the findings discussed in our study. In addition, depression was demonstrated to mediate the beneficial effect of social support on COPD outcomes. Higher social support was associated with better COPD outcomes in an adjusted cross-sectional analysis without depressive symptoms, while such associations were largely weakened when considering depressive symptoms. Depressive symptoms explained greater than 85% of the association between social support and measured COPD outcomes [29]. The GOLD stage was not correlated with any association between AECOPD and depression in this study (P = 0.654). A similar result (P = 0.093) was observed by Long et al. [26]. Most patients were in GOLD stages II–III, accounting for approximately 78% of all patients in this study. The association between AECOPD and depression and GOLD stages should be further investigated.

GABA is the most important inhibitory neurotransmitter in the mammalian central nervous system, and its dysfunction is involved in various mental and neurological diseases, such as depression and epilepsy [30,31]. Drugs that enhance GABAergic neurotransmission in the central nervous system have exhibited clinical benefits in treating mental and neurological diseases such as depression and epilepsy [31]. Positive depression status was reported to be related to lower levels of GABA-to-glutamate and GABA-to-glutamine ratios and higher levels of glutamate [32]. A study reported increased plasma GABA levels in patients with major depressive episodes [33]. GABA is expressed in bronchial epithelial cells, airway smooth muscle cells, and airway nerves. The GABAergic system in bronchial epithelial cells is excitatory rather than inhibitory, and its inhibition reduces mucus production [34]. Pulmonary neuroendocrine cells act through GABA to induce hyperplasia of goblet cells [35]. In addition, GABA was reported to reduce airway inflammation, and GABA in the epithelium exerted effects related to bronchial remodeling [36]. Gly is traditionally regarded as a non-essential amino acid and has been gradually recognized as being involved in tissue repair, oxidative stress, immunity, and metabolism in recent years [37,38]. Gly supplementation inhibited apoptosis and inflammation of alveolar cells and exerted a protective effect in pulmonary fibrosis [39,40]. Based on the observations described above, we speculated that the decreased serum GABA and Gly levels in patients with AECOPD with depression may be accompanied by increased airway inflammation.

NO, a potent vasoactive mediator, is generated from l-arginine by endothelial NO synthase. NO levels frequently change in patients with depression, and studies based on animal models have proposed that NO signals are targets of multiple antidepressants [41,42]. During the pathophysiology of major depression, NO signaling was observed to mediate inflammatory pathways [41]. Dysregulation of the endothelial NO pathway has been linked to airway inflammation in COPD [15]. Serum NO levels exhibited significant correlations with FEV1 and were independently associated with COPD [43]. A previous study reported inverse correlations between serum ADMA levels and NO levels in COPD [43]. In contrast, in another study, ADMA was reported to have positive correlations with blood neutrophil percentage and sputum neutrophil count [15]. Here, we observed that serum NO was increased in the AECOPD with depression group and that its expression was positively correlated with CAT score and AEs.

4.1 Strengths and limitations

This is the first study to investigate the associations between neuroactive substances and COPD complicated with depression. We demonstrated the potential predictive value of serum GABA, Gly, and NO levels regarding screening for AECOPD complicated with depression. However, this study does possess certain limitations. First, only patients with AECOPD were included, and patients with COPD in the stable stage, control individuals and/or stable depression without COPD were not analyzed. Second, depression in patients was evaluated using the SDS, which is a self-rating scale that reflects the emotional state of patients over a period of time. To assess depression more accurately, more than one scale (such as the Hamilton Depression Scale) should be used. Third, we preliminarily demonstrated the potential predictive value of GABA, Gly, and NO levels in AECOPD complicated with depression. Although the ROC curves indicated moderate predictive performance, the specificity of GABA and Gly was poor, and the sensitivity of NO was not high. Fourth, the sample size was small, and to ensure the reliability of the results, the sample size supporting this study design should be calculated in advance. Therefore, a well-designed study utilizing a larger sample size should further confirm the predictive value of GABA, Gly, and NO. The potential functions of GABA, Gly, and NO regarding the pathogenesis of AECOPD combined with depression should be explored.

5 Conclusion

In conclusion, our results revealed that serum GABA, Gly, and NO levels are significantly altered in patients with AECOPD complicated with depression compared to levels in those without depression and are closely correlated with two independent risk factors for AECOPD with depression: CAT score and number of AEs during the previous year. Therefore, serum GABA, Gly, and NO levels may provide useful biomarkers for AECOPD complicated with depression.


tel: +86-13994237390

  1. Funding information: Funding was provided by the Natural Science Foundation of Shanxi Province (No. 201901D111414), the Research Project Supported by the Shanxi Scholarship Council of China (No. 2020-178), and the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province (No. 20200029).

  2. Author contributions: All authors contributed to the study’s conception and design. Material preparation, data collection, and data analysis were performed by Wei Duan, Yanan Huang, and Mengyu Cheng. The first draft of the article was written by Mengyu Cheng, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–42.10.1016/S0140-6736(22)00470-6Search in Google Scholar PubMed

[2] Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. The Lancet Respiratory medicine. 2022;10(5):447–58.10.1016/S2213-2600(21)00511-7Search in Google Scholar PubMed PubMed Central

[3] Kahnert K, Jörres RA, Behr J, Welte T. The diagnosis and treatment of COPD and its comorbidities. Deutsches Arzteblatt Int. 2023;2023 Jun 23;(Forthcoming):arztebl.m2023.027.10.3238/arztebl.m2023.0027Search in Google Scholar

[4] Santos NCD, Miravitlles M, Camelier AA, Almeida VDC, Maciel R, Camelier FWR. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: A systematic review. Tuberculosis and Respiratory Diseases. 2022;85(3):205–20.10.4046/trd.2021.0179Search in Google Scholar PubMed PubMed Central

[5] Volpato E, Toniolo S, Pagnini F, Banfi P. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: A systematic review. Int J Chron Obstruct Pulmon Dis. 2021;16:2001–21.10.2147/COPD.S313841Search in Google Scholar PubMed PubMed Central

[6] Liu M, Li Y, Yin D, Wang Y, Fu T, Zhu Z, et al. COPD assessment test as a screening tool for anxiety and depression in stable COPD patients: A feasibility study. Copd. 2023;20(1):144–52.10.1080/15412555.2023.2174843Search in Google Scholar PubMed

[7] Blakemore A, Dickens C, Chew-Graham CA, Afzal CW, Tomenson B, Coventry PA, et al. Depression predicts emergency care use in people with chronic obstructive pulmonary disease: a large cohort study in primary care. Int J Chron Obstruct Pulmon Dis. 2019;14:1343–53.10.2147/COPD.S179109Search in Google Scholar PubMed PubMed Central

[8] Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–77.10.1378/chest.12-1911Search in Google Scholar PubMed

[9] Siraj RA, McKeever TM, Gibson JE, Bolton CE. Incidence of depression and antidepressant prescription in patients with COPD: A large UK population-based cohort study. Respir Med. 2022;196:106804.10.1016/j.rmed.2022.106804Search in Google Scholar PubMed

[10] Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–9.10.1183/09059180.00007813Search in Google Scholar PubMed PubMed Central

[11] Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102(1):75–90.10.1016/j.neuron.2019.03.013Search in Google Scholar PubMed PubMed Central

[12] Ayala-Lopez N, Watts SW. Physiology and pharmacology of neurotransmitter transporters. Comprehensive Physiology. 2021;11(3):2279–95.10.1002/cphy.c200035Search in Google Scholar PubMed

[13] Wang LS, Zhang MD, Tao X, Zhou YF, Liu XM, Pan RL, et al. LC-MS/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1112:24–32.10.1016/j.jchromb.2019.02.021Search in Google Scholar PubMed

[14] Nedic Erjavec G, Sagud M, Nikolac Perkovic M, Svob Strac D, Konjevod M, Tudor L, et al. Depression: Biological markers and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2021;105:110139.10.1016/j.pnpbp.2020.110139Search in Google Scholar PubMed

[15] Csoma B, Bikov A, Nagy L, Tóth B, Tábi T, Szűcs G, et al. Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD. Respir Res. 2019;20(1):156.10.1186/s12931-019-1133-8Search in Google Scholar PubMed PubMed Central

[16] Fu XW, Wood K, Spindel ER. Prenatal nicotine exposure increases GABA signaling and mucin expression in airway epithelium. Am J Respir Cell Mol Biol. 2011;44(2):222–9.10.1165/rcmb.2010-0109OCSearch in Google Scholar PubMed PubMed Central

[17] Suzuki R, Maehara R, Kobuchi S, Tanaka R, Ohkita M, Matsumura Y. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension. Life Sci. 2012;91(13–14):693–8.10.1016/j.lfs.2012.04.006Search in Google Scholar PubMed

[18] MacLeod M, Papi A, Contoli M, Beghé B, Celli BR, Wedzicha JA, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology. 2021;26(6):532–51.10.1111/resp.14041Search in Google Scholar PubMed

[19] Martínez-Gestoso S, García-Sanz MT, Carreira JM, Salgado FJ, Calvo-Álvarez U, Doval-Oubiña L, et al. Impact of anxiety and depression on the prognosis of copd exacerbations. BMC Pulm Med. 2022;22(1):169.10.1186/s12890-022-01934-ySearch in Google Scholar PubMed PubMed Central

[20] Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 gold science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36.10.1164/rccm.202009-3533SOSearch in Google Scholar PubMed PubMed Central

[21] Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol. 2006;90(1):75–80.10.1136/bjo.2005.073643Search in Google Scholar PubMed PubMed Central

[22] Fang L, Gao P, Bao H, Tang X, Wang B, Feng Y, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. The Lancet Respiratory medicine. 2018;6(6):421–30.10.1016/S2213-2600(18)30103-6Search in Google Scholar PubMed PubMed Central

[23] Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.10.1183/09031936.00102509Search in Google Scholar PubMed

[24] Houben-Wilke S, Janssen DJA, Franssen FME, Vanfleteren L, Wouters EFM, Spruit MA. Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores. Health and quality of life outcomes. 2018;16(1):205.10.1186/s12955-018-1034-4Search in Google Scholar PubMed PubMed Central

[25] Liu Y, Tian X, Guo X, Wu B, Wang L, Wang S, et al. Prevalence of anxiety and depression in chronic obstructive pulmonary disease. Chinese Journal of Respiratory and Critical Care Medicine. 2020;19(5):425–9.Search in Google Scholar

[26] Long J, Ouyang Y, Duan H, Xiang Z, Ma H, Ju M, et al. Multiple factor analysis of depression and/or anxiety in patients with acute exacerbation chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:1449–64.10.2147/COPD.S245842Search in Google Scholar PubMed PubMed Central

[27] Underner M, Cuvelier A, Peiffer G, Perriot J, Jaafari N. The influence of anxiety and depression on COPD exacerbations. Rev Mal Respir. 2018;35(6):604–25.10.1016/j.rmr.2018.04.004Search in Google Scholar PubMed

[28] Wu D, Zhao X, Huang D, Dai Z, Chen M, Li D, et al. Outcomes associated with comorbid anxiety and depression among patients with stable COPD: A patient registry study in China. J Affect Disord. 2022;313:77–83.10.1016/j.jad.2022.06.059Search in Google Scholar PubMed

[29] Turnier L, Eakin M, Woo H, Dransfield M, Parekh T, Krishnan JA, et al. The influence of social support on COPD outcomes mediated by depression. PLoS One. 2021;16(3):e0245478.10.1371/journal.pone.0245478Search in Google Scholar PubMed PubMed Central

[30] Lu K, Hong Y, Tao M, Shen L, Zheng Z, Fang K, et al. Depressive patient-derived GABA interneurons reveal abnormal neural activity associated with HTR2C. EMBO Mol Med. 2023;15(1):e16364.10.15252/emmm.202216364Search in Google Scholar PubMed PubMed Central

[31] Wang YS, Qiu TY, Fu Q, Xiong SQ, Wang ZZ, Lu MF, et al. Unravelling biological roles and mechanisms of GABA(B)R on addiction and depression through mood and memory disorders. Biomed Pharmacother. 2022;155:113700.10.1016/j.biopha.2022.113700Search in Google Scholar PubMed

[32] Huang T, Balasubramanian R, Yao Y, Clish CB, Shadyab AH, Liu B, et al. Associations of depression status with plasma levels of candidate lipid and amino acid metabolites: a meta-analysis of individual data from three independent samples of US postmenopausal women. Mol Psychiatry. 2021;26(7):3315–27.10.1038/s41380-020-00870-9Search in Google Scholar PubMed PubMed Central

[33] Bhandage AK, Cunningham JL, Jin Z, Shen Q, Bongiovanni S, Korol SV, et al. Depression, GABA, and age correlate with plasma levels of inflammatory markers. International journal of molecular sciences. 2019;20(24):6172.10.3390/ijms20246172Search in Google Scholar PubMed PubMed Central

[34] Xiang YY, Wang S, Liu M, Hirota JA, Li J, Ju W, et al. A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat Med. 2007;13(7):862–7.10.1038/nm1604Search in Google Scholar PubMed

[35] Sui P, Wiesner DL, Xu J, Zhang Y, Lee J, Van Dyken S, et al. Pulmonary neuroendocrine cells amplify allergic asthma responses. Science. 2018;360:6393.10.1126/science.aan8546Search in Google Scholar PubMed PubMed Central

[36] Pavón-Romero GF, Serrano-Pérez NH, García-Sánchez L, Ramírez-Jiménez F, Terán LM. Neuroimmune pathophysiology in asthma. Frontiers in Cell and Developmental Biology. 2021;9:663535.10.3389/fcell.2021.663535Search in Google Scholar PubMed PubMed Central

[37] Rasmussen BF, Ennis MA, Dyer RA, Lim K, Elango R. Glycine, a dispensable amino acid, is conditionally indispensable in late stages of human pregnancy. J Nutr. 2021;151(2):361–9.10.1093/jn/nxaa263Search in Google Scholar PubMed PubMed Central

[38] Ji Y, Fan X, Zhang Y, Li J, Dai Z, Wu Z. Glycine regulates mucosal immunity and the intestinal microbial composition in weaned piglets. Amino Acids. 2022;54(3):385–98.10.1007/s00726-021-02976-ySearch in Google Scholar PubMed

[39] Ma X, Zhang Y, Jiang D, Yang Y, Wu G, Wu Z. Protective effects of functional amino acids on apoptosis, inflammatory response, and pulmonary fibrosis in lipopolysaccharide-challenged mice. J Agric Food Chem. 2019;67(17):4915–22.10.1021/acs.jafc.9b00942Search in Google Scholar PubMed

[40] Zhang Y, Ma X, Jiang D, Chen J, Jia H, Wu Z, et al. Glycine attenuates lipopolysaccharide-induced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling. Nutrients. 2020;12(3):611.10.3390/nu12030611Search in Google Scholar PubMed PubMed Central

[41] Ghasemi M. Nitric oxide: Antidepressant mechanisms and inflammation. Adv Pharmacol. 2019;86:121–52.10.1016/bs.apha.2019.04.004Search in Google Scholar PubMed

[42] Eshaghi E, Sadigh-Eteghad S, Mohaddes G, Rasta SH. Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: A study of three different doses of 810 nm laser. Lasers Surg Med. 2019;51(7):634–42.10.1002/lsm.23082Search in Google Scholar PubMed

[43] Aydin M, Altintas N, Cem Mutlu L, Bilir B, Oran M, Tülübaş F, et al. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Clin Respir J. 2017;11(3):318–27.10.1111/crj.12337Search in Google Scholar PubMed

Received: 2023-04-13
Revised: 2023-07-12
Accepted: 2023-07-30
Published Online: 2023-08-29

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0693/html?lang=en
Scroll to top button